Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Gastrointestinal effects: Retatrutide, like other GLP-1 receptor agonists, commonly causes nausea, vomiting, and reduced appetite, as documented in the SmPCs for licensed GLP-1-based medicines such as semaglutide and tirzepatide
It contains the first 29 amino acids of GHRH, which is the biologically active fragment responsible for stimulating somatotroph cells in your anterior pituitary gland to synthesize and release growth hormone
Patients treated with tirzepatide demonstrated consistently lower post-treatment prevalence of gastrointestinal and systemic adverse events across response strata, despite achieving higher magnitude and faster weight reductions
Cachexia Sarcopenia Muscle
US$ 29.10
US$ 25.83
US$ 24.25
